Riggs Asset Managment Co. Inc. - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 50 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 1.28 and the average weighting 0.0%.

Quarter-by-quarter ownership
Riggs Asset Managment Co. Inc. ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q1 2018$5,000
+66.7%
1,0000.0%0.00%
+100.0%
Q4 2017$3,000
+50.0%
1,0000.0%0.00%0.0%
Q3 2017$2,0000.0%1,0000.0%0.00%0.0%
Q2 2017$2,0000.0%1,0000.0%0.00%0.0%
Q1 2017$2,0001,0000.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 184,742$565,0000.18%
D.A. DAVIDSON & CO. 851,101$2,604,0000.05%
Iron Gate Global Advisors LLC 17,090$52,0000.02%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$37,0000.02%
IHT Wealth Management, LLC 28,155$86,0000.01%
OSAIC HOLDINGS, INC. 1,012,430$3,098,0000.01%
Ameritas Investment Company, LLC 10,782$33,0000.01%
Vivaldi Capital Management LP 15,439$40,0000.01%
CENTAURUS FINANCIAL, INC. 15,614$48,0000.01%
Geneos Wealth Management Inc. 37,017$108,0000.01%
View complete list of GALECTIN THERAPEUTICS INC shareholders